Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Oleptiss 360 mg Tablet
Manufacturer/Marketed By : Sandoz Private Limited
$72.53 $71.40
Oleptiss 360 mg Tablet is an effective treatment option designed to manage chronic iron overload in individuals aged six and older who suffer from transfusion-dependent anemias, making it essential for...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Deferasirox 360 mg
Active Pharmaceutical Ingredient
Oleptiss 360 mg Tablet
72,53$
71,40$
Oleptiss 360 mg Tablet is an effective treatment option designed to manage chronic iron overload in individuals aged six and older who suffer from transfusion-dependent anemias, making it essential for those requiring frequent blood transfusions. This medication is also suitable for younger patients, specifically those between two to five years old, who have transfusion-dependent anemias and do not respond adequately to deferoxamine therapy. Moreover, Oleptiss 360 mg is beneficial for patients aged ten and above with non-transfusion-dependent thalassemia syndromes, providing a comprehensive approach to iron overload management. By targeting excess iron in the body, Oleptiss helps prevent potential complications associated with iron accumulation, thereby improving overall health and quality of life. It is important to note that while using Oleptiss, patients should be monitored for possible side effects and interactions with other medications. Always consult with a healthcare professional before starting treatment to ensure it aligns with individual health needs and conditions. With its targeted formulation, Oleptiss 360 mg Tablet stands out as a reliable choice for those facing the challenges of chronic iron overload.
Active Pharmaceutical Ingredient
Uses
• Oleptiss 360 mg tablet is primarily indicated for the management of iron overload in patients who have received multiple blood transfusions. This condition can occur in individuals with chronic anemia or other blood disorders. The tablet helps to reduce excess iron accumulation in the body, which can lead to serious health complications. By effectively managing iron levels, Oleptiss 360 mg tablet supports better overall health.
• In pediatric patients with genetic blood disorders, Oleptiss 360 mg tablet plays a crucial role in preventing iron overload. These conditions often require frequent blood transfusions, increasing the risk of iron buildup. The medication aids in maintaining a balanced iron level, thereby minimizing potential damage to vital organs. Regular use of Oleptiss 360 mg tablet can enhance the quality of life for young patients facing this challenge.
• Oleptiss 360 mg tablet is also beneficial for adults experiencing iron overload due to underlying medical conditions. It helps mitigate the risks associated with excessive iron, such as damage to the liver and heart. By facilitating the safe removal of surplus iron, Oleptiss 360 mg tablet contributes to better long-term health outcomes. Healthcare providers often recommend this treatment as part of a comprehensive care plan for affected individuals.
• The use of Oleptiss 360 mg tablet is essential in managing chronic conditions that lead to iron accumulation. Its formulation is designed to effectively bind excess iron, promoting its excretion from the body. This action is particularly important for patients undergoing regular blood transfusions or those with specific hereditary conditions. Incorporating Oleptiss 360 mg tablet into treatment regimens can significantly enhance patient well-being and health management.
Benefits
Treatment of Iron overload: Iron overload is a medical condition where there is an excessive buildup of iron in the body, often resulting from genetic blood disorders like thalassemia or hemochromatosis, or repeated blood transfusions. This condition can harm organs like the liver, heart, and pancreas, leading to serious health issues. Oleptiss 360 mg Tablet can decrease the excess iron to safe levels by removing it from the body through stools. This treatment helps lower the risk of organ damage and prevents further complications. To get the maximum benefit, take Oleptiss 360 mg as directed by your doctor.
Side Effects
Many medications, Oleptiss 360 mg Tablet can cause side effects, but most of them are temporary and go away as the body adjusts to the medicine. However, if the side effects persist or worsen, or if you are concerned about them, it is important to consult your doctor.
Most Common Side Effects
• Nausea
• Headache
• Vomiting
• Rash
Common Side Effects
• Abdominal pain
• Constipation
• Itching
• Increased liver enzymes
• Abdominal distension
• Diarrhoea
How To Use
Oleptiss 360 mg Tablet should be taken on an empty stomach at least 30 minutes before eating the first meal of the day, preferably at the same time each day for better results. The dosage and frequency will be determined by your doctor based on your specific condition and may change over time. It is very important that you follow your doctor's instructions and do not change the dosage or frequency of intake without their guidance. Taking Oleptiss 360 mg in the wrong or excessive amounts may cause serious side effects. It may take several weeks or months for the full effects of treatment to appear, but you should not stop taking it without consulting your doctor.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Oleptiss 360 mg. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Oleptiss 360 mg Tablet. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Oleptiss 360 mg Tablet is not recommended for use in patients with kidney disease as it may be unsafe for them. It is important to consult with a doctor before using Oleptiss 360 mg to ensure that the medication is safe and appropriate for the individual patient's medical condition.
• Breastfeeding: Oleptiss 360 mg Tablet is considered safe to use during breastfeeding. Although limited human data is available, it suggests that the medication does not pose a significant risk to the baby.
• Liver: Oleptiss 360 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Oleptiss 360 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Oleptiss 360 mg may need to be adjusted in patients with liver disease
• Pregnancy: Use of Oleptiss 360 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Oleptiss 360 mg Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Oleptiss 360 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Oleptiss 360 mg Tablet.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.